[YMAB] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[YMAB] Y-mAbs Therapeutics, Inc.
Announcement Date
10-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -23.64%
YoY- 85.11%
Quarter Report
YMAB's Result
YMAB's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 22,798 20,751 10,797 10,951 0 0 0 -
PBT -9,149 -6,123 -41,131 -22,937 -40,393 -18,036 -10,305 -1.96%
Tax 100 179 1,186 -216 0 0 0 -
NP -9,249 -6,302 -42,317 -22,937 -40,393 -18,036 -10,305 -1.78%
Tax Rate - - - - - - - -
Total Cost 32,047 27,053 53,114 33,888 40,393 18,036 10,305 20.79%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -40.57 -30.37 -391.93 -209.45 0.00 0.00 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.21 -0.14 -0.97 -0.53 -1.01 -0.53 -0.32 -6.77%
EPS Diluted -0.21 -0.14 -0.97 -0.53 -1.01 -0.53 -0.32 -6.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.